Article Data

  • Views 1010
  • Dowloads 167

Reviews

Open Access

Conservative surgical treatment of uterine fibroids in women of childbearing age

  • Hongxia Yu1
  • Shoufeng Zhang1
  • Wendi Zhang1
  • Huimin Tang2
  • Yao Chen3
  • Zhiyong Dong2
  • Zhenyue Qin1
  • Junling Liu2
  • Huihui Wang1
  • Mingyue Bao1
  • Weiwei Wei2
  • Ruxia Shi2
  • Bairong Xia3,*,
  • Jiming Chen2,*,

1Dalian Medical University, 116000 Dalian, Liaoning, China

2Department of Gynecology, The Affiliated Changzhou Second People’s Hospital of Nanjing Medical University, 213000 Changzhou, Jiangsu, China

3Department of Gynecology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, 230031 Hefei, Anhui, China

DOI: 10.22514/ejgo.2023.053 Vol.44,Issue 4,August 2023 pp.1-5

Submitted: 03 September 2022 Accepted: 18 October 2022

Published: 15 August 2023

*Corresponding Author(s): Bairong Xia E-mail: xiabairong@ustc.edu.cn
*Corresponding Author(s): Jiming Chen E-mail: cjming@126.com

Abstract

Uterine fibroids are benign gynecologic tumors, and women aged between 30 to 50 years are known to have a high incidence of uterine fibroids. A growing number of pharmacotherapies and minimally invasive organ-preserving treatments have been designed and conducted over the past few years. However, there has not been any therapeutic drugs exhibiting an ideal therapeutic effect and low recurrence rate, such that the surgical treatment continues to be primarily employed in the actual clinical treatment. In general, surgical treatment has been performed as the organ- and fertility-preserving hysteroscopic or laparoscopic resections of the fibroids. Minimally invasive surgical equipment (e.g., hysteroscopy, traditional porous laparoscopy, trans-umbilical laparoscopy, transvaginal laparoscopy, as well as robot-assisted laparoscopy) has been extensively applied to clinical treatment. Compared with traditional laparotomy, minimally invasive surgical equipment is characterized by minimally invasive surgery, high efficiency and safety. As medical technology has been leaping forward, interventional therapy and radiofrequency ablation can also be employed for treating uterine fibroids. In accordance with the research progress worldwide, the current situation, limitations, and advantages of the treatment of uterine fibroids in patients with fertility requirements are reviewed in this study.


Keywords

Uterine fibroids; Myomectomy; Uterine artery embolization; High-Intensity focused ultrasound; Radiofrequency ablation; Pregnancy; Fertility


Cite and Share

Hongxia Yu,Shoufeng Zhang,Wendi Zhang,Huimin Tang,Yao Chen,Zhiyong Dong,Zhenyue Qin,Junling Liu,Huihui Wang,Mingyue Bao,Weiwei Wei,Ruxia Shi,Bairong Xia,Jiming Chen. Conservative surgical treatment of uterine fibroids in women of childbearing age. European Journal of Gynaecological Oncology. 2023. 44(4);1-5.

References

[1] Grube M, Neis F, Brucker SY, Kommoss S, Andress J, Weiss M, et al. Uterine fibroids—current trends and strategies. Surgical Technology International. 2019; 34: 257–263.

[2] Orellana M, Riggan KA, DSouza K, DSouza K, Stewart EA, Venable S, et al. Perceptions of ethnoracial factors in the management and treatment of uterine fibroids. Journal of Racial and Ethnic Health Disparities. 2022; 9: 1184–1191.

[3] Johnson JA, Tough S. Delayed child-bearing. Journal of Obstetrics and Gynaecology Canada. 2012; 34: 80–93.

[4] Rakotomahenina H, Rajaonarison J, Wong L, Brun J. Myomectomy: technique and current indications. Minerva Obstetrics and Gynecology. 2017; 69: 357–369.

[5] Wise LA, Laughlin-Tommaso SK. Epidemiology of uterine fibroids. Clinical Obstetrics & Gynecology. 2016; 59: 2–24.

[6] Lee HJ, Kim SJ, Park EC. Psychiatric outcomes after hysterectomy in women with uterine myoma: a population-based retrospective cohort study. Archives of Women’s Mental Health. 2017; 20: 487–494.

[7] Loddo A, Djokovic D, Drizi A, De Vree BP, Sedrati A, van Herendael BJ. Hysteroscopic myomectomy: the guidelines of the international society for gynecologic endoscopy (ISGE). European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2022; 268: 121–128.

[8] Brady PC, Stanic AK, Styer AK. Uterine fibroids and subfertility: an update on the role of myomectomy. Current Opinion in Obstetrics & Gynecology. 2013; 25: 255–259.

[9] Yang Y, Yang Y, You M, Chen L, Sun F. Observation of pregnancy outcomes in patients with hysteroscopic resection on submucous myomas. The Journal of Obstetrics and Gynaecology Research. 2022; 48: 360–365.

[10] Tinelli A, Kosmas IP, Carugno JT, Carp H, Malvasi A, Cohen SB, et al. Uterine rupture during pregnancy: The URIDA (uterine rupture international data acquisition) study. International Journal of Gynaecology and Obstetrics 2022; 157: 76–84.

[11] Haviv E, Schwarzman P, Bernstein EH, Wainstock T, Weintraub AY, Leron E, et al. Subsequent pregnancy outcomes after abdominal vs. laparoscopic myomectomy. The Journal of Maternal-fetal & Neonatal Medicine. 2021; 1–7.

[12] Zapardiel I, Boria F, Halaska MJ, De Santiago J. Laparoscopic power morcellation: techniques to avoid tumoral spread. Journal of Minimally Invasive Gynecology. 2021; 28: 1442–1443.

[13] Wang W, Liang H, Zhao F, Yu H, Rong C, Feng W, et al. A novel multiport containment system for laparoscopic power morcellation to prevent tumoral spread: a retrospective cohort study. Frontiers in Surgery. 2022; 9: 803950.

[14] Sleiman Z, Baba RE, Garzon S, Khazaka A. The significant risk factors of intra-operative hemorrhage during laparoscopic myomectomy: a systematic review. Gynecology and Minimally Invasive Therapy. 2020; 9: 6–12.

[15] Gitas G, Hanker L, Rody A, Ackermann J, Alkatout I. Robotic surgery in gynecology: is the future already here? Minimally Invasive Therapy & Allied Technologies. 2022; 31: 815–824.

[16] Özbaşlı E, Güngör M. Comparison of perioperative outcomes among robot-assisted, conventional laparoscopic, and abdominal/open myomectomies. Journal of the Turkish-German Gynecological Association. 2021; 22: 312–318.

[17] Lee D, Lee JR, Suh CS, Kim SH. A systematic review and meta-analysis comparing single port laparoscopic myomectomy with conventional laparoscopic myomectomy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2019; 239: 52–59.

[18] Jiang L, Tong D, Li Y, Liu Q, Liu K. Application of single-port laparoscopic surgery in myomectomy. Frontiers in Oncology. 2021; 11: 722084.

[19] Baekelandt J. Transvaginal natural-orifice transluminal endoscopic surgery: a new approach to myomectomy. Fertility and Sterility. 2018; 109: 179.

[20] Russ M, Hees KA, Kemmer M, Richter R, Kröncke T, Schnapauff D, et al. Preoperative uterine artery embolization in women undergoing uterus-preserving myomectomy for extensive fibroid disease: a retrospective analysis. Gynecologic and Obstetric Investigation. 2022; 87: 38–45.

[21] Davis MR, Soliman AM, Castelli-Haley J, Snabes MC, Surrey ES. Reintervention rates after myomectomy, endometrial ablation, and uterine artery embolization for patients with uterine fibroids. Journal of Women’s Health. 2018; 27: 1204–1214.

[22] Kröncke T, David M; participants of the Consensus Meeting. Uterine artery embolization (UAE) for fibroid treatment—results of the 5th radio-logical gynecological expert meeting. Geburtshilfe und Frauenheilkunde. 2015; 75: 439–441.

[23] Ghanaati H, Sanaati M, Shakiba M, Bakhshandeh H, Ghavami N, Aro S, et al. Pregnancy and its outcomes in patients after uterine fibroid embolization: a systematic review and meta-analysis. Cardiovascular and Interventional Radiology. 2020; 43: 1122–1133.

[24] Sanders AP, Norris S, Tulandi T, Murji A. Reproductive outcomes following uterine artery occlusion at the time of myomectomy: systematic review and meta-analysis. Journal of Obstetrics and Gynaecology Canada. 2020; 42: 787–797.e782.

[25] Pron G. Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) treatment of symptomatic uterine fibroids: an evidence-based analysis. Ontario Health Technology Assessment Series. 2015; 15: 1–86.

[26] Torres-de la Roche LA, Rafiq S, Devassy R, Verhoeven HC, Becker S, De Wilde RL. Should ultrasound-guided high frequency focused ultrasound be considered as an alternative non-surgical treatment of uterine fibroids in non-Asiatic countries? An opinion paper. Journal of Clinical Medicine. 2022; 11: 839.

[27] Römer T, Bends R, Christoffel L, Felberbaum R, Hildebrandt T, Meinhold-Heerlein I, et al. The significance of transcervical ultrasound-guided radiofrequency ablation in the treatment of symptomatic fibroids: results of an expert consensus from German-speaking countries. Archives of Gynecology and Obstetrics. 2022; 306: 1–6.

[28] Piriyev E, Schiermeier S, Bends R, Römer T. Transcervical radiofre-quency ablation of fibroids that are 5 cm or larger in women with abnormal uterine bleeding. Journal of Gynecology Obstetrics and Human Reproduction. 2022; 51: 102303.

[29] Iavazzo C, Psomiadou V, Fotiou A, Vrachnis N. Concerns about transcervical radiofrequency ablation of uterine fibroids. Journal of Gynecology Obstetrics and Human Reproduction. 2022; 51: 102325.

[30] Christoffel L, Bends R, Toub D, Schiermeier S, Pschadka G, Engelhardt M, et al. Pregnancy outcomes after transcervical radiofrequency ablation of uterine fibroids with the sonata system. Journal of Gynecologic Surgery. 2022; 38: 207–213.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top